\
&
Contact us
\
&
Contact us
A handy Excel file, weekly updated, containing an up-to-date overview of the Horizon Europe calls
It goes without saying, the main sources of information on the call topics are the Funding & Tenders Portal and the Work Programmes. You can find direct links on each of the (sub)programme pages of this website.
However, sometimes you are just in need of a good overview to quickly find back relevant information or to follow-up certain initiatives in your organisation. This is why NCP Flanders provides, as an extra service, Excel files with the essential call topic information. For now, this exists in 2 variants, and the information in both is exactly the same:
As we're just starting this service, all client feedback is welcome. Simply send a mail to info@ncpflanders.be with your comments and suggestions.
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
